|
시장보고서
상품코드
2058210
수의용 백신 보조제 시장 : 제품 유형별, 동물 유형별, 투여 경로별, 용도별, 최종 사용자별, 지역별Veterinary Vaccine Adjuvants Market, By Product Type, By Animal Type, By Route of Administration, By Application, By End User, By Geography |
||||||
수의용 백신 보조제 시장은 2026년에 4억 1,000만 달러에 달하고 2033년까지 6억 4,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR은 6.6%를 나타낼 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 4억 1,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 6.60% | 시장 규모 예측(2033년) : | 6억 4,000만 달러 |
수의용 백신 보조제는 동물용 백신의 성능, 안정성 및 효능 향상을 보장하는 중요한 성분입니다. 이는 가축이나 반려동물의 면역력을 높이는 데 도움이 되며, 백신의 효과에 큰 영향을 미칩니다. 인수공통전염병의 위협 증가, 가축 사육 두수 증가, 그리고 동물 예방의료에 대한 관심 고조가 전 세계 모든 지역에서 첨단 보조제에 대한 수요를 견인하는 주요 요인이 되고 있습니다.
세계 동물용 백신 보조제 시장은 유성 에멀젼, 고분자계 시스템, 나노입자계 제제 등 다양한 제품으로 구성되어 있습니다. 시장은 아쥬반트 개발 및 동물용 백신 적용 분야에서 점차 더 새로운 기술로 전환되고 있습니다. 반려동물 사육 마릿수 증가, 동물 백신 접종에 대한 인식 제고, 그리고 동물 예방접종을 지원하는 정부의 우호적인 정책이 시장 역학에 영향을 미치는 주요 요인입니다. 면역학 분야의 신기술 도입과 다가 백신 및 종 특이적 백신에 보조제를 접목하는 것 또한 향후 몇 년간 유망한 비즈니스 기회를 가져다줄 것입니다.
시장 역학
수의용 백신 보조제 시장은 가축 및 반려동물의 감염병 및 인수공통감염병 발생률 증가에 힘입어 성장하고 있습니다. 그 결과, 예방접종 전략에 대한 필요성이 커지고 있습니다. 세계적인 단백질 수요 증가에 따라 축산업이 급속히 발전하는 가운데, 감염병 및 질병 예방의 역할이 특히 중요해지고 있으며, 이는 백신 보조제를 활용한 예방접종의 도입 확대로 이어지고 있습니다. 또한, 반려동물 수 증가와 반려인들의 동물 건강에 대한 관심 증대, 그리고 건강 관리에 대한 지출 증가에 따라 백신 제품 사용도 늘어나고 있습니다.
그러나 이 업계는 제품 승인, 개발, 안전 기준에 관한 엄격한 규제 등 여러 제약에 직면해 있으며, 이러한 요인들이 프로세스를 지연시키고 추가 비용으로 이어질 수 있습니다. 게다가, 동물 종 간의 개체 차이와 기존 보조제에 대한 부작용 또한 또 다른 걸림돌이 되고 있습니다. 게다가 개발도상국에서는 첨단 의료 솔루션이나 인프라가 충분히 갖춰져 있지 않다는 문제도 있습니다.
그럼에도 불구하고, 차세대 백신 보조제 등의 혁신, 백신 접종 프로그램에 대한 정부 기관 및 국제 기구의 관심 증가, 그리고 예방적 동물 관리의 확산으로 인해 시장에는 수많은 성장 기회가 존재합니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 파라미터(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)를 바탕으로 세계 수의용 백신 보조제 시장의 주요 기업 프로파일을 작성하였습니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 수의용 백신 보조제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업 및 금융 분석가를 포함한 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 수의용 백신 보조제 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 수의용 백신 보조제 시장 : 제품 유형별(2021-2033년)
제5장 세계의 수의용 백신 보조제 시장 : 동물 유형별(2021-2033년)
제6장 세계의 수의용 백신 보조제 시장 : 투여 경로별(2021-2033년)
제7장 세계의 수의용 백신 보조제 시장 : 용도별(2021-2033년)
제8장 세계의 수의용 백신 보조제 시장 : 최종 사용자별(2021-2033년)
제9장 세계의 수의용 백신 보조제 시장 : 지역별(2021-2033년)
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
KTHVeterinary Vaccine Adjuvants Market is estimated to be valued at USD 410 Mn in 2026 and is expected to reach USD 640 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 410 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.60% | 2033 Value Projection: | USD 640 Mn |
Veterinary vaccine adjuvants are important constituents that ensure better performance, stability and improved efficacy of animal vaccines. They help boost the immunity levels in livestock and pets and provide a significant impact on the effectiveness of the vaccines. The increasing threat of zoonosis, rising livestock numbers, and greater focus on preventive care for animals are the major drivers behind the demand for sophisticated adjuvants in all regions around the world.
The global veterinary vaccines adjuvants market is dominated by a wide range of products such as oil emulsions, polymer-based systems, and nanoparticle-based formulations. The market is moving towards newer technologies in the creation of adjuvants and their usage in animal vaccines. Growing pet ownership, higher awareness about animal vaccination, and favorable government policies in support of animal immunization are the main factors influencing market dynamics. The introduction of new technology in the field of immunology and the inclusion of adjuvants in multivalent and species-specific vaccines will also offer lucrative opportunities in the coming years.
Market Dynamics
The veterinary vaccine adjuvants market is propelled by the rising incidences of infectious and zoonotic diseases among farm and companion animals. As a result, there is an increasing need for immunization strategies. With the rapid development of livestock production due to increasing protein demands around the world, the role of preventing infections and diseases becomes especially important, which leads to the greater implementation of immunizations based on vaccine adjuvants. Additionally, the increase in pets' numbers and pet owners' interest in animal health, alongside their expenditures on veterinary healthcare, leads to the increase in vaccine products use.
Nonetheless, the industry is faced with several limitations, such as strict regulation in terms of product approval, development, and safety standards, which might slow down the process and lead to extra costs. Moreover, individual differences between animal species and adverse reactions to conventional adjuvants constitute additional barriers. Additionally, there is insufficient availability of advanced healthcare solutions and infrastructure in less developed countries.
Nevertheless, there are numerous growth opportunities on the market because of innovations, including new-generation vaccine adjuvants, the increased interest of government agencies and international organizations in vaccination programs; and the rise in preventive animal care.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global veterinary vaccine adjuvants market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Zoetis Inc., Merck Animal Health, Elanco Animal Health, Ceva Sante Animale, Boehringer Ingelheim Animal Health, HIPRA, Phibro Animal Health Corporation, Virbac, Vaxxinova, and Seppic
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global veterinary vaccine adjuvants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary vaccine adjuvants market
Market Segmentation
- Product Type Insights (Revenue, USD Mn, 2021 - 2033)
- Aluminum-based Adjuvants
- Oil-based Adjuvants
- Emulsion-based Adjuvants
- Others
- Animal Type Insights (Revenue, USD Mn, 2021 - 2033)
- Livestock Animals
- Companion Animals
- Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
- Injectable
- Oral
- Intranasal
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Bacterial Vaccines
- Viral Vaccines
- Parasitic Vaccines
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Veterinary Pharmaceutical and Biopharmaceutical Companies
- Contract Research and Manufacturing Organizations (CROs/CMOs)
- Research and Academic Institutes
- Veterinary Clinics and Hospitals
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Zoetis Inc.
- Merck Animal Health
- Elanco Animal Health
- Ceva Sante Animale
- Boehringer Ingelheim Animal Health
- HIPRA
- Phibro Animal Health Corporation
- Virbac
- Vaxxinova
- Seppic
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Veterinary Vaccine Adjuvants Market, By Product Type
- Global Veterinary Vaccine Adjuvants Market, By Animal Type
- Global Veterinary Vaccine Adjuvants Market, By Route of Administration
- Global Veterinary Vaccine Adjuvants Market, By Application
- Global Veterinary Vaccine Adjuvants Market, By End User
- Global Veterinary Vaccine Adjuvants Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Veterinary Vaccine Adjuvants Market, By Product Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Aluminum-based Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Oil-based Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Emulsion-based Adjuvants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Veterinary Vaccine Adjuvants Market, By Animal Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Livestock Animals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Companion Animals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Veterinary Vaccine Adjuvants Market, By Route of Administration, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Intranasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Veterinary Vaccine Adjuvants Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Bacterial Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Viral Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Parasitic Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Veterinary Vaccine Adjuvants Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Veterinary Pharmaceutical and Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Contract Research and Manufacturing Organizations (CROs/CMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Research and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Veterinary Clinics and Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Veterinary Vaccine Adjuvants Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Animal Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Zoetis Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck Animal Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Elanco Animal Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ceva Sante Animale
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim Animal Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HIPRA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Phibro Animal Health Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Virbac
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vaxxinova
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Seppic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
